Animal Drug Compounding Industry Forecast to Hit $2.38 Billion by 2029 With a Strong 7.4% CAGR
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Animal Drug Compounding Market Size During 2025–2029?
The animal drug compounding market size has experienced significant growth in recent years. It is forecast to increase from $1.67 billion in 2024 to $1.79 billion in 2025, at a compound annual growth rate (CAGR) of 7.0%. The expansion observed in the historic period stems from factors such as the regulatory landscape, veterinary practices, market awareness, limited commercial options, and veterinary collaboration.
The animal drug compounding market is set to experience substantial growth in the upcoming years. It is predicted to expand to $2.38 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.4%. The projected growth can be attributed to evolving regulatory developments, increasing pet ownership trends, advancements in specialized veterinary care, the globalization of veterinary services, and ongoing advancements in veterinary medicine. Key trends anticipated during the forecast period include an emphasis on flavoring and palatability, a rising demand for specialized dosage forms, enhanced collaboration between veterinarians and compounding pharmacists, a focus on effective pain management solutions, and an expanding role in veterinary hospice care.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9964&type=smp
What Are The Drivers Pushing New Developments In The Animal Drug Compounding Market?
The increasing rate of animal adoption is projected to drive the expansion of the animal drug compounding market. Animal adoption is defined as obtaining animals through rescue groups rather than purchasing them from pet shops or breeders. Adopted animals frequently have pre-existing health conditions or require medications not available in standard formulations, thus creating a demand for customized animal medications. As more pet owners seek tailored medications for their adopted animals, the need for animal drug compounding increases. For instance, in October 2023, Novuna, a UK-based financial service company, reported that approximately 10,070 dogs were adopted, indicating an 11.06% increase compared to 2022. This demonstrates that the rise in the rate of animal adoption is fueling the growth of the animal drug compounding market.
Which Key Segments Fueling The Animal Drug Compounding Market?
The animal drug compounding market covered in this report is segmented –
1) By Animal Type: Companion Animals, Livestock Animals
2) By Product: Anti-Infective Agents, Anti-inflammatory Agents, Hormones And Substitutes, CNS Agents, Other Products
3) By Route Of Administration: Oral, Injectable, Topical, Other Routes Of Administration
4) By Application: Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers
Subsegments:
1) By Companion Animals: Dogs, Cats, Horses, Other Small Mammals
2) By Livestock Animals: Cattle, Swine, Poultry, Sheep, Goats
Which Ongoing Trends Are Expected To Shape The Animal Drug Compounding Market Outlook?
Leading companies in the animal drug compounding market are developing innovative products, including feline-friendly formulations, to enhance the safety and effectiveness of medications tailored specifically for cats. Feline-friendly formulations refer to products specifically designed to be safe, effective, and appealing for cats. For instance, in September 2024, Wedgewood, a US-based veterinary pharmaceutical company, launched compounded molnupiravir. Compounded molnupiravir is an antiviral drug specifically for treating Feline Infectious Peritonitis (FIP) in cats. It offers feline-friendly formulations of molnupiravir, available in various dosages designed to treat different forms of FIP, including effusive, non-effusive, neurological, and ocular types. This involves producing different dosages and flavors, including flavored oral oil suspensions and capsules, to meet the specific requirements of individual feline patients.
Which Major Industry Participants Are Leading The Animal Drug Compounding Market Growth?
Major companies operating in the animal drug compounding market include Wedgewood Pharmacy LLC, Triangle Compounding Pharmacy Inc., Davis Islands Pharmacy & Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South LLC, Wellness Compounding Pharmacy of Cary LLC, Miller’s Pharmacy, Caringbah Compounding Pharmacy Pty. Ltd., Smith Drug and Compounding Inc., Specialist Compounding Pharmacy Pte Ltd., Tache Pharmacy & Medical Supplies, Hoye’s Pharmacy, Vertisis Custom Pharmacy LLC, Smith-Caldwell Drug Store Inc., Sixth Avenue Medical Pharmacy, Pharmaca Integrative Pharmacy Inc., Akina Animal Health, Letco Medical LLC, The Pet Apothecary LLC, Vetsource Inc., Roadrunner Pharmacy, Medisca Inc., BCP Veterinary Pharmacy, VetRxDirect LLC, Diamondback Drugs, Vetcentric Pty. Ltd., Pet Health Pharmacy, PetMed Express Inc., PetRx2Go, South Wellness Pharmacy
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report
What Are The Key Regional Factors Influencing The Animal Drug Compounding Market Growth?
North America was the largest region in the animal drug compounding market in 2024. The regions covered in the animal drug compounding market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Animal Drug Compounding Market Report:
https://www.thebusinessresearchcompany.com/customise?id=9964&type=smp
Browse Through More Reports Similar to the Global Animal Drug Compounding Market 2025, By The Business Research Company
Cardiovascular Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report
Dermatology Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report
Gastrointestinal Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
